XML 27 R16.htm IDEA: XBRL DOCUMENT
v3.25.1

Weighted Average Shares Outstanding | 3 Months Ended
--- | ---
Mar. 31, 2025
Earnings Per Share [Abstract] |
WEIGHTED AVERAGE SHARES OUTSTANDING | NOTE I – WEIGHTED AVERAGE SHARES OUTSTANDING
| Three Months Ended March 31, |  |
(in millions) | 2025 |  | 2024 |  |  |  |
Weighted average shares outstanding — basic | 1,477.2 |  |  | 1,468.4 |  |  |  |  |
Net effect of common stock equivalents | 15.9 |  |  | 13.4 |  |  |  |  |
Weighted average shares outstanding - diluted | 1,493.1 |  |  | 1,481.7 |  |  |  |  |
The following securities were excluded from the calculation of weighted average shares outstanding - diluted because their effect in the periods presented below would have been antidilutive:
| Three Months Ended March 31, |  |
(in millions) | 2025 |  | 2024 |  |  |  |
Stock options outstanding(1) | 1 |  | 2 |  |  |  |
(1) Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods. We base Net income (loss) per common share - diluted upon the weighted-average number of common shares and common stock equivalents outstanding during each year. Potential common stock equivalents are determined using the treasury stock method. We exclude stock options and stock awards from the calculation if the effect would be anti-dilutive. We issued approximately five million shares of our common stock in the first quarter of 2025 and approximately four million shares in the first quarter of 2024. Shares were issued following the exercise of stock options, vesting of restricted stock units or purchases under our employee stock purchase plan. We did not repurchase any shares of our common stock in the first quarter of 2025 or 2024. On December 14, 2020, our Board of Directors approved a stock repurchase program authorizing the repurchase of up to $1.000 billion of our common stock. As of March 31, 2025, we had the full amount remaining available under the authorization.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration